The options issue and spp raise were a bit of a shocker for management. I'm glad they can at least sort out tax rebates effectively.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025